simendan has been researched along with Ventricular Septal Perforation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZJ; Cheng, YQ; Li, ZS; Liu, C; Pan, T; Sun, YH; Wang, DJ; Wang, K; Zhang, H; Zhang, HT | 1 |
| Camilli, M; Ciampi, P; Crea, F; D'Aiello, A; Liuzzo, G; Massetti, M; Mazza, A; Montone, RA; Pedicino, D; Rebuzzi, AG; Sanna, T | 1 |
2 other study(ies) available for simendan and Ventricular Septal Perforation
| Article | Year |
|---|---|
The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis.
Topics: Acute Disease; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Hydrazones; Male; Myocardial Infarction; Postoperative Complications; Propensity Score; Prospective Studies; Pyridazines; Simendan; Ventricular Septal Rupture | 2022 |
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report.
Topics: Aged; Cardiac Surgical Procedures; Humans; Male; Simendan; Ventricular Septal Rupture | 2021 |